Leap Therapeutics’ $40 Million Private Placement

Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in the transaction.Leap Therapeutics, Inc. (Nasdaq:LPTX) has entered into a securities purchase agreement with a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here